87717949 - EVOLVE BIOLOGICS

Information

• Trademark
• 87717949

• Source

• Serial Number

  87717949

• Registration Number

  6297748

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 37 - Building construction
  • 40 - Treatment of materials
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 12, 2017
  7 years ago

• Registration Date

  March 23, 2021
  4 years ago

• Transaction Date

  August 10, 2021
  4 years ago

• Status Date

  March 23, 2021
  4 years ago

• Published for Opposition Date

  January 05, 2021
  4 years ago

• Location Date

  July 07, 2021
  4 years ago

• Status Code

  700

• Current Location

  TMEG LAW OFFICE 103

  Employee Name

  MORENO, PAUL A

• Attorney Docket Number

  7933.828US01

  Attorney Name

  Christopher J. Schulte

  Law Office Assigned Location Code

  L30

• Owners

  • THERAPURE BIOPHARMA INC

Case File Statements

• B00001: In the statement, page 2, line 9, "EVLOVE" should be deleted, and "EVOLVE" should be inserted.
• CC0000: Color is not claimed as a feature of the mark.
• D10000: "BIOLOGICS"
• DM0000: The mark consists of the word "EVOLVE" in stylized lettering with the "V" forming into the "O" with the word "BIOLOGICS" underneath the letters "LVE" in stylized format.
• GS0051: Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methods
• GS0371: Construction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities
• GS0401: Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics
• GS0411: Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment
• GS0421: Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biolotics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate

Case File Event Statements

• 7/7/2021 - 4 years ago

  53 - REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD Type: CORV

• 7/7/2021 - 4 years ago

  52 - CORRECTION UNDER SECTION 7 ¿ PROCESSED Type: COC.

• 7/1/2021 - 4 years ago

  51 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 4/19/2021 - 4 years ago

  50 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 3/23/2021 - 4 years ago

  49 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/5/2021 - 4 years ago

  48 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/5/2021 - 4 years ago

  47 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/16/2020 - 4 years ago

  46 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/1/2020 - 4 years ago

  45 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 11/26/2020 - 4 years ago

  44 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/25/2020 - 4 years ago

  43 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/25/2020 - 4 years ago

  42 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/25/2020 - 4 years ago

  41 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/6/2020 - 5 years ago

  40 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/6/2020 - 5 years ago

  39 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/6/2020 - 5 years ago

  38 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/25/2020 - 5 years ago

  37 - LETTER OF PROTEST EVIDENCE FORWARDED Type: LOPT

• 2/12/2020 - 5 years ago

  36 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/12/2020 - 5 years ago

  35 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/12/2020 - 5 years ago

  34 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/28/2020 - 5 years ago

  33 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 1/14/2020 - 5 years ago

  32 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 1/1/2020 - 5 years ago

  31 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK

• 12/30/2019 - 5 years ago

  30 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD

• 12/27/2019 - 5 years ago

  29 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR

• 12/19/2019 - 5 years ago

  28 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/18/2019 - 5 years ago

  27 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/18/2019 - 5 years ago

  26 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/13/2019 - 5 years ago

  25 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 11/27/2019 - 5 years ago

  24 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK

• 10/30/2019 - 5 years ago

  23 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK

• 6/19/2019 - 6 years ago

  22 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 6/19/2019 - 6 years ago

  21 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 6/19/2019 - 6 years ago

  20 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 11/30/2018 - 6 years ago

  19 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 11/30/2018 - 6 years ago

  18 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 11/30/2018 - 6 years ago

  17 - SUSPENSION LETTER WRITTEN Type: CNSL

• 11/7/2018 - 6 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/7/2018 - 6 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/30/2018 - 6 years ago

  14 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 5/3/2018 - 7 years ago

  13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 5/3/2018 - 7 years ago

  12 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 5/3/2018 - 7 years ago

  11 - SUSPENSION LETTER WRITTEN Type: CNSL

• 5/3/2018 - 7 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/3/2018 - 7 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/1/2018 - 7 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 4/24/2018 - 7 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/16/2018 - 7 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/16/2018 - 7 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/16/2018 - 7 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/14/2018 - 7 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/22/2017 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 12/15/2017 - 7 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP